机器人内镜传导性隔膜肌切除术和同时进行的对心膜修复,以治疗超大缩性阻塞性心肌病
Yazan N Yazan N AlJamal1, Hiroto Kitahara2, Husam Balkhy3
1Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA.
Multimedia manual of cardiothoracic surgery : MMCTS
|June 14, 2023
概括
超阻塞性心肌病 (HOCM) 治疗包括减少左心室外流通道阻塞. 机器人辅助外科手术提供了一个安全的替代方案,以椎切除手术的程序,如隔膜肌切除在HOCM.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 医疗技术 医疗技术 医学技术
背景情况:
- 超大致阻塞性心肌病 (HOCM) 的特征是左心室外流通道阻塞.
- 这种阻塞源于中枢与心室内隔膜之间的相互作用.
- 截面肌切除术是HOCM的既定黄金标准治疗方法.
研究的目的:
- 审查HOCM的替代外科治疗方法.
- 评估机器人辅助心脏手术在治疗HOCM中的作用.
主要方法:
- 对HOCM各种外科手术技术的文献综述.
- 对交叉,交叉和传导方法的结果分析.
- 评估机器人辅助隔膜切除术和 mitra 门修复.
主要成果:
- 多种手术方法可以有效地减少左心室外流通道梯度.
- 机器人辅助心脏手术是一种安全有效的胸腔切除术的替代方案.
- 经验丰富的中心利用机器人方法进行隔膜肌切除术和中枢修复.
结论:
- 各种手术方法有效地管理HOCM.
- 机器人辅助手术为HOCM治疗提供了一个可行的,不那么侵入性的选择.
相关概念视频
Mitral Stenosis III: Medical Management
14
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
14
Cardiomyopathy V: Interprofessional Care
18
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
18
Cardiomyopathy III: Hypertrophic Cardiomyopathy
17
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Cardiomyopathy VII: Pre and Post Operative Nursing Management
16
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
16
Mitral Regurgitation III: Medical Management
20
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
20
Mitral Valve Prolapse II: Assessment and Management
23
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
23


